Moreover, the anti-obesity drug liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, can alleviate airway inflammation by suppressing NLRP3 inflammasome activity (Hur et al., 2021). The gene discussed is NLRP3; the disease is obesity disorder.